Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Voice Scams: When AI Calls Your Patients, Who’s Responsible?
In 2025, 38% of Americans reported receiving scam calls where fraudsters impersonated their healthcare providers, a surge driven by AI‑generated deepfake voices. Multi‑modal campaigns—combining texts, calls, and emails—have amplified the threat, exemplified by the Kettering Health outage that disrupted patient services for weeks. Surveys show 77% of Americans fear AI‑based impersonation, with Gen Z hit hardest at 53% of respondents. Healthcare organizations are now prioritizing voice‑channel security through branding, call authentication, and spoof protection to curb regulatory fines and reputational damage.
Benefits of All on 4 Dental Implants Compared to Traditional Dentures
All‑on‑4 dental implants, using four strategically placed titanium posts, restore up to 70‑80% of natural bite force and preserve jawbone density, addressing the limitations of traditional dentures that lose up to 25% chewing efficiency within a year. The fixed solution...
First Patient Dosed in CatalYm’s Phase IIb Visugromab Trial
CatalYm announced the first patient has been dosed in its Phase IIb GDFATHER‑HCC‑01 trial, evaluating visugromab as a second‑line therapy for unresectable or metastatic hepatocellular carcinoma. The blinded, randomized study combines visugromab with the PD‑1 inhibitor nivolumab and the tyrosine‑kinase inhibitor...
MOH Releases Details on Updated Salary Guidelines for Community Care Staff in Singapore
Singapore’s Ministry of Health released updated salary guidelines for the community care sector on 8 April 2026, recommending roughly a 7 % increase in total annual compensation for most roles. The new tables detail starting and mid‑point monthly base salaries and median annual...
What Parents Should Know Before Their Child’s First Dental Visit in New Braunfels
The American Dental Association reports that 23% of children ages 2‑5 suffer tooth decay, yet many New Braunfels parents delay their child’s first dental visit until problems appear. Pediatric dentistry recommends scheduling the initial exam by age one, or within...
Halozyme and Vertex Sign Deal for Hypercon Technology
Halozyme Therapeutics’ Hypercon unit has inked a global exclusive licence with Vertex Pharmaceuticals to apply its Hypercon microparticle platform to up to three drug targets. Vertex will pay Halozyme an upfront $15 million plus potential milestones and royalties on any resulting...
STAT+: A Decade Ago, These Drugs Tore Apart the FDA. Today, They Might Be some Patients’ Best Hope
Exon‑skipping therapies for Duchenne muscular dystrophy, once a source of controversy at the FDA, are now delivering unexpected clinical benefits. A recent trial involving 39 patients, including 5‑year‑old Hawken Miller, showed functional improvements that have surprised leading experts. The drugs,...
Is Invisalign Right for Me? Key Considerations and Benefits
Clear aligner therapy, led by Invisalign, now accounts for over 40% of U.S. orthodontic cases, up from 15% a decade ago. The treatment appeals to teens and adults because it’s discreet, removable, and avoids dietary restrictions. Success hinges on patient...
20 Future Swiss HealthTech and MedTech Leaders
Swiss life sciences is shifting from pharmaceutical dominance to a deep‑tech health ecosystem, backed by a surge in venture capital that reached CHF 2.9 bn (≈$3.2 bn) in 2025 – a 23.9% increase. ETH Zurich alone spun out 46 new ventures, leveraging an...
Compassionate Workplaces Are Key to Curing Medical Burnout
Why loving organizations are the secret to ending burnout in medicine [PODCAST] http://dlvr.it/TRwgsy Podcast #HospitalBasedMedicine
Clarity Signs Manufacturing Supply Agreement for Copper-64 With Theragenics
Clarity Pharmaceuticals has signed a large‑scale manufacturing supply agreement with Theragenics to produce copper‑64 (Cu‑64) at Theragenics’ 134,000‑sq‑ft facility near Atlanta. Theragenics can generate about 100 Ci (3.7 TBq) of Cu‑64 per day per cyclotron, enough for roughly 2,000 patient doses. The...
Startup Pitches Brainless Human Clones for Organ Harvesting
Big news about a startup called R3 Bio that plans to create brainless human clones for the sole purpose of harvesting organs when people need them. They are just pitching the idea to investors now, but it is pretty wild (if...
Mint Explainer | Anthropic’s $400-Million Biotech Bet: What It Means for India’s Pharma Industry
Anthropic, the creator of the Claude AI model, has acquired stealth biotech startup Coefficient Bio for $400 million in an all‑stock transaction. Coefficient, founded by former Genentech computational drug discovery scientists, brings expertise in AI‑driven molecule design. The purchase underscores a...
European VC Jeito Gets $1.2B to Help Private Biotechs Control Their 'Destiny'
Jeito Capital, a Paris‑based venture firm, closed its second fund at $1.2 billion (over €1 billion, roughly $1.08 billion). The capital will be deployed to a dozen or so European drug‑development startups seeking to advance pre‑clinical and early‑stage clinical programs. By providing sizable,...
As CGT Manufacturing Scales Up, Automation and Collaboration Become Essential
Cell and gene therapy manufacturing faces a scalability crunch as single batches cost over $500,000 and skilled labor shortages drive high turnover. Companies are turning to robotics, AI, and digital dashboards to automate processes, cut contamination risk, and harness real‑time...
WAFIOS Hosts 2nd Annual Medical Tech Day in Mokena
WAFIOS Machinery Corporation will hold its second Annual Medical Tech Day on June 3, 2026 at its Midwest Technical Center in Mokena, Illinois. The one‑day event gathers medical device manufacturers, technology partners and industry experts to showcase precision manufacturing solutions...
Red Meat Consumption Linked to Lower Risk of Dementia
A long‑term Swedish cohort study of more than 2,100 adults over 15 years found that higher consumption of unprocessed red meat was associated with a slower rate of cognitive decline and roughly half the dementia risk among carriers of the...
Indonesia, UK Shift Research From Lab to Real-World Solutions
Indonesia and the United Kingdom are expanding joint research through the International Science Partnerships Fund, emphasizing the translation of lab discoveries into practical solutions. The partnership, coordinated by the British Council and the UK Department for Science, Innovation and Technology,...
'Doctors Thought My Endometriosis Was IBS'
Endometriosis patients in the UK are facing record‑long diagnosis delays, with new Endometriosis UK data showing an average wait of nine years and four months, up from eight years in 2020. Women like Jade Boden‑de Mel and Emily Knell recount being misdiagnosed with...
Daré's CEO Wants Everyone To Invest in Women’s Health, Starting With Her Company
Daré Bioscience, led by CEO Sabrina Martucci Johnson, launched a Regulation A offering to raise $24.3 million, allowing individuals to invest as little as $250. The biotech focuses exclusively on women’s‑health therapeutics, including menopause, fertility, and vaginal‑health products, with its first solo...
Radiology Pushes for $45M to Fund Federal Physician Burnout Program
The American College of Radiology, together with dozens of physician societies, urged Congress to allocate at least $45 million to the Lorna Breen Mental Health Act, the nation’s only federal program aimed at preventing physician burnout and suicide. Since its 2022 launch,...
Siemens Healthineers Partnership Seeks to Boost Supply of Novel PET Imaging Agent
Siemens Healthineers has signed a clinical supply agreement with Australian biotech Radiopharm Theranostics to manufacture and distribute the novel PET imaging agent RAD101 in the United States. The fluorine‑18‑labeled small molecule targets suspected recurrent brain cancer that has metastasized and...
Blackstone and TPG Finalize Hologic Acquisition:
Blackstone and TPG have completed the acquisition of Hologic at $79 per share, including contingent value rights, marking one of the largest med‑tech buyouts of the year. The deal signals a resurgence of mega‑cap private‑equity activity after a period of...
Over 50% of Heart Attacks in Younger Women Aren't From Clogged Arteries
A recent Journal of the American College of Cardiology analysis of patients 65 and younger found that more than half of heart attacks in women are driven by mechanisms other than atherosclerotic plaque, such as oxygen‑supply mismatch, spontaneous artery tears,...
Kent and Medway Mental Health Services Consolidated Under Single NHS Trust
Kent and Medway Mental Health NHS Trust has assumed responsibility for children and young people's mental health services, adult mental health care and eating‑disorder treatment across the region. The integration, effective April 2026, creates the first single‑trust model for these...
WHO Unveils Global Curriculum Guide to Boost Community Health Workers
The World Health Organization today released a Global Curriculum Guide for Community Health Workers and a step‑by‑step integration manual. The resources are designed to help ministries of health improve competency‑based training and embed CHW programs into national health systems, a...
Children’s Hospital Colorado Halts Gender‑Affirming Care for Trans Youth
Children’s Hospital Colorado announced it will cease providing gender‑affirming medical services to transgender patients under 18, a move that has unsettled families and health‑care providers. The decision, made in early 2026, arrives amid a national clash over pediatric transgender care...
Gamified mHealth App Boosts Fitness, Cognition and Mood in College Students, RCT Shows
A randomized controlled trial of 160 Chinese college students found that a gamified mobile health app increased daily steps by 2,114, added 28 minutes of moderate‑to‑vigorous activity per day, and improved executive function and depressive symptoms. The study demonstrates a...
EU Launches PsyPal Project to Test Psychedelic‑Assisted Therapy for Palliative Care Distress
On April 13, 2026, the European Union’s Directorate‑General for Health and Food Safety unveiled the EU‑funded PsyPal project, a research programme that will test psychedelic‑assisted therapy for psychological distress in palliative‑care patients. The initiative signals a policy‑driven push to examine...
Experimental Weight‑loss Drug Retatrutide Sparks TikTok Alarm over Relationship Side‑effects
A TikTok video alleging that experimental obesity drug retatrutide dulls love and libido has gone viral, prompting users to share similar experiences. Researchers and clinicians warn that the drug’s impact on the brain’s reward system could have broader emotional consequences,...
Akeso Reports 7‑month Median PFS for Cadonilimab Combo in PD-(L)1‑resistant NSCLC
Akeso presented updated Phase Ib/II results at ELCC 2026 showing a 7.0‑month median progression‑free survival and a 95.2% disease‑control rate for its cadonilimab‑anlotinib‑docetaxel regimen in patients whose advanced NSCLC progressed after PD-(L)1 therapy. The data suggest a viable second‑line option...
Do Healthcare CEOs Agree on Whether VBC and MA Actually Save Money?
Healthcare CEOs debated whether value‑based care (VBC) and Medicare Advantage (MA) actually cut costs. Some executives, like Arcadia’s Michael Meucci and Risant Health’s Jaewon Ryu, see untapped potential in fraud‑reduction and population‑health management, while others, such as Shawn Gremminger, claim...
Zoll Names Eric Knudsen CEO, Keeps EMT Role Amid Growth Surge
Zoll announced Eric Knudsen as its new chief executive, noting he will retain his volunteer EMT work. The appointment comes as the company’s revenue has risen to $2.4 billion, nearly five‑fold since its 2011 acquisition by Asahi Kasei.
Genetically Engineered Silkworms Spin Spider Silk, a Material Five Times Stronger Than Steel
Researchers have successfully re‑programmed silkworms to spin spider‑silk protein, a fiber five times stronger than steel. The breakthrough, highlighted in National Geographic, could reshape the $6 trillion chemical industry and open high‑strength biomaterial markets in medicine, textiles and sustainable manufacturing.
Global Drug Makers Face Pricing Pressure as China Targets Affordable Healthcare
Global drug makers are confronting intensified pricing pressure in China as Beijing expands its volume‑based procurement scheme and pushes affordable healthcare through deep discounts. While innovative therapies listed on the national reimbursement drug list (NRDL) gain market volume, mature off‑patent...
Telehealth Abortion Will Remain Available for Now, After a Federal Judge's Ruling
A federal judge in Louisiana granted a stay on a lawsuit challenging the FDA's 2023 rule that permits telehealth prescribing of the abortion pill mifepristone. The decision keeps medication abortions available nationwide while the agency completes a safety review, which...
ACL Tears Can Heal Naturally Without Surgery
The ACL CAN heal on its own. Without surgery. 53% of ACL ruptures managed with rehabilitation alone showed complete healing on MRI at 2 years. Patients who healed reported better sport function and quality of life than the non-healed group and better than...
GSK's Depemokimab Gains Chinese Approval for Nasal Polyps
#GSK Exdensur (depemokimab) approved in China for treating Chronic Rhinosinusitis with Nasal Polyps, following the ANCHOR trials.
Scalable Biologics Production Trends: Featuring Omar Wahab of Lonza — Breakthrough, Episode 250
In episode 250 of the Xtalks Life Science Podcast, Lonza’s Vice President of Bioprocessing Omar Wahab explains why cell‑culture media is a strategic lever for scalable biologics manufacturing. He argues that early formulation choices influence downstream productivity, product quality, and...
Lithium Reverses ApoE4 Cellular Deficits, Merits AD Trials
https://t.co/r6JzHA1RxM with ApoE4/E4 from a sporadic Alzheimer's disease patient "Given the drug's demonstrated efficacy in reversing ApoE4-driven cellular vulnerabilities, lithium salt warrants further investigation for the treatment of AD." https://t.co/r6JzHA1RxM https://t.co/v2lE0XhN7n
HHS Allegedly Fuels Wellness Influencer Pseudoscience Against Vaccines
ANS self evident, Dept HHS had built a pseudoscience parallel universe for the highly corrupt wellness influencer industry. Attacks on vaccines to prop up fake supplements, ivermectin just the beginning, the peptides are next level, but there’s more coming as...
Study: Improving Healthcare 'Just as Critical' As Cutting Emissions in Fight Against Air Pollution
A new Lancet study finds that improving access to quality healthcare is as vital as cutting emissions for reducing premature deaths caused by air pollution. Researchers modelled global mortality and showed that strengthening health systems could prevent millions of deaths,...
Targeting Liver ApoE Boosts Bone Healing in the Elderly
Neutralizing hepatic apolipoprotein E enhances aged bone fracture healing "Our work here identifies novel liver-to-bone cross-talk and a noninvasive, translatable therapeutic intervention for aged bone regeneration" https://t.co/KSzvkKOzZt https://t.co/1p0cXQlalT
Α‑Eleostearic Acid Acts as Senolytic via Ferroptosis
α-eleostearic acid as a senolytic via ferroptosis. Found in high concentrations in Tung oil (which is toxic) and in small amounts in Bitter Melon oil. https://t.co/FSCix3OZtD
Obesity Pills: Orforglipron Outpaces Semaglutide: Next-Gen Oral GLP-1 Agonist Drives Superior Glycemic and Weight Control
The phase 3 ACHIEVE‑3 trial showed that oral orforglipron outperformed oral semaglutide in both glycemic control and weight loss for type 2 diabetes patients. At 52 weeks, the 36 mg dose reduced HbA1c by 1.91% versus 1.47% for semaglutide and achieved an 8.2% weight...
Three‑Month Omega‑3 Trial Cuts Stress and Boosts Sleep in Adults
In a double‑blind trial of 64 adults with high stress, daily omega‑3 capsules for three months produced statistically significant improvements in stress, anxiety, depression, sleep quality and everyday memory. The findings, published in the Journal of Affective Disorders, suggest a...
Feds Pump $48M Into New Health R&D Centre
The Canadian federal government is allocating $48 million CAD (≈$35 million USD) to Providence Healthcare’s Clinical Support & Research Centre (CSRC) in Vancouver, creating an advanced innovation hub. The hub will house a Clinical Trials Unit, an XR‑enabled Simulation Centre, a Health...
ED Serving Double the Patients It Was Designed For
The emergency department at Michael Garron Hospital in Toronto is now treating more than 300 patients a day—double the 150‑patient capacity it was built for 30 years ago. Annual visits jumped to about 107,000, far exceeding the original design target...
Rethinking the Microbiology Workflow with Smarter Tools for Faster Answers and Less Waste
Bruker unveiled an integrated microbiology platform that combines rapid identification, antimicrobial susceptibility testing, same‑day strain typing and next‑generation sequencing analytics. The MALDI Biotyper can analyze up to 600 isolates per hour on a 96‑spot plate, while the IR Biotyper delivers...
Protect Yourself From Rising Medicare Fraud
Medicare beneficiaries face escalating fraud schemes as the Financial Crimes Enforcement Network (FinCEN) issues a new advisory urging vigilance. Expert Jae Oh stresses that fraud typically starts with stolen personal data, making beneficiaries the first line of defense. He recommends...